#AtRiskMASH - Twitter Hashtag

Mónica Tincopa MD MSc DABOM @MonicaTincopa

almost 2 years ago

How do our current #MASLD care algorithms meet the needs of the #Hispanic #Latinx community? 🔹⬇️ accuracy of #NIT at currently recommended cutpoints to detect #AtRiskMASH #AdvancedFibrosis 🔹⬇️ cutpoints may be needed given ⬆️ disease prevalence/severity https://t.co/CM1xgAKd9t

MonicaTincopa's tweet photo. How do our current #MASLD care algorithms meet the needs of the #Hispanic #Latinx community?
🔹⬇️ accuracy of #NIT at currently recommended cutpoints to detect #AtRiskMASH #AdvancedFibrosis
🔹⬇️ cutpoints may be needed given ⬆️ disease prevalence/severity
https://t.co/CM1xgAKd9t https://t.co/xpIHgOIFPj

0

23

5

2

2K

Mónica Tincopa MD MSc DABOM @MonicaTincopa

over 2 years ago

Our review with @DrLoomba & @QAnstee on #MASH therapeutics is out now in @Cell_Metabolism Herein we highlight: 🔵#NITs to detect #AtRiskMASH & advanced fibrosis 🔵recently approved and emerging pharmacotherapy 🔵#NITs for treatment response @UCSDHealthSci @MASLDResearch

Daniel J Drucker @DanielJDrucker

over 2 years ago

In 5 years, what will the preferred therapies for #MASH look like? @DrLoomba @Cell_Metabolism https://t.co/pwEnB2Th9H

2

83

39

18K

0

5

1

0

610

Mónica Tincopa MD MSc DABOM @MonicaTincopa

almost 3 years ago

Stephen Harrison reviewing data on over 6000 patients in #MASH clinical trials to identify what combination of screening data minimizes screen fails and optimizes enrollment to identify #AtRiskMASH -combination of A12, AST, and FAST useful guiding parameters #TLM2023

MonicaTincopa's tweet photo. Stephen Harrison reviewing data on over 6000 patients in #MASH clinical trials to identify what combination of screening data minimizes screen fails and optimizes enrollment to identify #AtRiskMASH
-combination of A12, AST, and FAST useful guiding parameters
#TLM2023 https://t.co/K8t6fNhnqy

0

3

1

0

505

Top Tweets for #AtRiskMASH

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users